Cardiac Sarcoidosis Clinical Trial
Official title:
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
Verified date | March 2023 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using 18F-FSPG PET/MRI (or PET/CT for participants with metal implants).
Status | Terminated |
Enrollment | 45 |
Est. completion date | September 28, 2021 |
Est. primary completion date | September 28, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient is = 18 years old at the time of the scan - Patient with known or suspected cardiac sarcoidosis. - Patient is capable of complying with study procedures - Patient can remain still for duration of imaging procedure Exclusion Criteria: - Patient is pregnant or nursing - Metallic implants (contraindicated for MRI) - History of renal insufficiency (only for MRI contrast administration) |
Country | Name | City | State |
---|---|---|---|
United States | Stanford University | Stanford | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University | GE Healthcare |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With 18F-FSPG Uptake on PET/MRI or PET/CT Fused Images Indicating Cardiac Involvement of Sarcoidosis | Diffuse (widespread), focal (point) and focal-on-diffuse (combination of the two) patterns of 18F-FSPG uptake will be considered to be positive findings indicating cardiac involvement of sarcoidosis or inflammation | average approximately 2 hours | |
Secondary | Number of Participants With Evidence of Whole Body 18F-FSPG Uptake on PET/MRI or PET/CT Fused Images Indicating Extra-cardiac Sarcoidosis | The whole-body PET/MRI images will be evaluated for findings of extra-cardiac sarcoidosis. Evidence of 18F-FSPG uptake within the whole body will indicate a positive finding for the presence of extra-cardiac sarcoidosis. | average approximately 2 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03705884 -
PET/MR Imaging In Patients With Cardiac Sarcoidosis
|
N/A | |
Recruiting |
NCT04017936 -
Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis
|
Phase 2 | |
Recruiting |
NCT06131112 -
Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis
|
||
Terminated |
NCT03923049 -
Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis
|
N/A | |
Not yet recruiting |
NCT05954507 -
Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis
|
N/A | |
Recruiting |
NCT04737317 -
Diagnostic Criteria in Cardiac Sarcoidosis
|
||
Recruiting |
NCT06409585 -
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
|
||
Recruiting |
NCT03057002 -
UTSW HP [13-C] Pyruvate Injection in HCM
|
||
Completed |
NCT03599414 -
CASPA: CArdiac Sarcoidosis in PApworth
|
||
Withdrawn |
NCT02812849 -
Somatostatin Receptor Imaging in Cardiac Sarcoidosis
|
||
Completed |
NCT01729169 -
Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET
|
N/A | |
Completed |
NCT03549598 -
d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis
|
Phase 4 | |
Recruiting |
NCT04758650 -
Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis
|
Phase 2 | |
Recruiting |
NCT04206163 -
Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis
|
N/A | |
Recruiting |
NCT05499637 -
[68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation
|
Phase 2 | |
Recruiting |
NCT03593759 -
Cardiac Sarcoidosis Randomized Trial
|
Phase 3 | |
Recruiting |
NCT05145023 -
Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis
|
||
Enrolling by invitation |
NCT04774549 -
Inflammatory Cardiomyopathy Bern Registry
|
||
Recruiting |
NCT03049254 -
Mayo AVC Registry and Biobank
|
||
Completed |
NCT03746847 -
PET Imaging in Patients With Suspected Cardiac Sarcoidosis
|